These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32941248)

  • 1. Novel classifications for systemic sclerosis: challenging historical subsets to unlock new doors.
    Sobanski V; Lescoat A; Launay D
    Curr Opin Rheumatol; 2020 Nov; 32(6):463-471. PubMed ID: 32941248
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using Autoantibodies and Cutaneous Subset to Develop Outcome-Based Disease Classification in Systemic Sclerosis.
    Nihtyanova SI; Sari A; Harvey JC; Leslie A; Derrett-Smith EC; Fonseca C; Ong VH; Denton CP
    Arthritis Rheumatol; 2020 Mar; 72(3):465-476. PubMed ID: 31682743
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenotypes Determined by Cluster Analysis and Their Survival in the Prospective European Scleroderma Trials and Research Cohort of Patients With Systemic Sclerosis.
    Sobanski V; Giovannelli J; Allanore Y; Riemekasten G; Airò P; Vettori S; Cozzi F; Distler O; Matucci-Cerinic M; Denton C; Launay D; Hachulla E;
    Arthritis Rheumatol; 2019 Sep; 71(9):1553-1570. PubMed ID: 30969034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thinking outside the box--The associations with cutaneous involvement and autoantibody status in systemic sclerosis are not always what we expect.
    Srivastava N; Hudson M; Tatibouet S; Wang M; Baron M; Fritzler MJ;
    Semin Arthritis Rheum; 2015 Oct; 45(2):184-9. PubMed ID: 25959492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systematic Analysis of the Literature in Search of Defining Systemic Sclerosis Subsets.
    Nevskaya T; Pope JE; Turk MA; Shu J; Marquardt A; van den Hoogen F; Khanna D; Fransen J; Matucci-Cerinic M; Baron M; Denton CP; Johnson SR
    J Rheumatol; 2021 Nov; 48(11):1698-1717. PubMed ID: 33993109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progress in understanding the diagnostic and pathogenic role of autoantibodies associated with systemic sclerosis.
    Choi MY; Fritzler MJ
    Curr Opin Rheumatol; 2016 Nov; 28(6):586-94. PubMed ID: 27387266
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies in systemic sclerosis and fibrosing syndromes: clinical indications and relevance.
    Cepeda EJ; Reveille JD
    Curr Opin Rheumatol; 2004 Nov; 16(6):723-32. PubMed ID: 15577611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lung involvement in systemic sclerosis (scleroderma): relation to classification based on extent of skin involvement or autoantibody status.
    Kane GC; Varga J; Conant EF; Spirn PW; Jimenez S; Fish JE
    Respir Med; 1996 Apr; 90(4):223-30. PubMed ID: 8736656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differentially expressed genes in systemic sclerosis: Towards predictive medicine with new molecular tools for clinicians.
    Keret S; Rimar D; Lansiaux P; Feldman E; Lescoat A; Milman N; Farge D;
    Autoimmun Rev; 2023 Jun; 22(6):103314. PubMed ID: 36918090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Belgian Systemic Sclerosis Cohort: correlations between disease severity scores, cutaneous subsets, and autoantibody profile.
    Vanthuyne M; Smith V; De Langhe E; Van Praet J; Arat S; Depresseux G; Westhovens R; Blockmans D; Badot V; Cogan E; De Keyser F; Houssiau FA
    J Rheumatol; 2012 Nov; 39(11):2127-33. PubMed ID: 22984273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional insights into pathogenesis of cutaneous systemic sclerosis using pathway driven meta-analysis assisted by machine learning methods.
    Xu X; Ramanujam M; Visvanathan S; Assassi S; Liu Z; Li L
    PLoS One; 2020; 15(11):e0242863. PubMed ID: 33253326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
    Hamaguchi Y
    J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies against specific extractable nuclear antigens (ENAs) as diagnostic and prognostic tools and inducers of a profibrotic phenotype in cultured human skin fibroblasts: are they functional?
    Corallo C; Cheleschi S; Cutolo M; Soldano S; Fioravanti A; Volpi N; Franci D; Nuti R; Giordano N
    Arthritis Res Ther; 2019 Jun; 21(1):152. PubMed ID: 31234888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disease subsets, antinuclear antibody profile, and clinical features in 127 French and 247 US adult patients with systemic sclerosis.
    Meyer OC; Fertig N; Lucas M; Somogyi N; Medsger TA
    J Rheumatol; 2007 Jan; 34(1):104-9. PubMed ID: 17117486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early systemic sclerosis: analysis of the disease course in patients with marker autoantibody and/or capillaroscopic positivity.
    Valentini G; Marcoccia A; Cuomo G; Vettori S; Iudici M; Bondanini F; Santoriello C; Ciani A; Cozzolino D; De Matteis GM; Cappabianca S; Vitelli F; Spanò A
    Arthritis Care Res (Hoboken); 2014 Oct; 66(10):1520-7. PubMed ID: 24515450
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune complexes containing scleroderma-specific autoantibodies induce a profibrotic and proinflammatory phenotype in skin fibroblasts.
    Raschi E; Chighizola CB; Cesana L; Privitera D; Ingegnoli F; Mastaglio C; Meroni PL; Borghi MO
    Arthritis Res Ther; 2018 Aug; 20(1):187. PubMed ID: 30157947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The concept of early systemic sclerosis following 2013 ACR\EULAR criteria for the classification of systemic sclerosis.
    Valentini G; Marcoccia A; Cuomo G; Iudici M; Vettori S
    Curr Rheumatol Rev; 2014; 10(1):38-44. PubMed ID: 24720644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early trajectories of skin thickening are associated with severity and mortality in systemic sclerosis.
    Ledoult E; Launay D; Béhal H; Mouthon L; Pugnet G; Lega JC; Agard C; Allanore Y; Jego P; Fauchais AL; Harlé JR; Berthier S; Aouba A; Mekinian A; Diot E; Truchetet ME; Boulon C; Duhamel A; Hachulla E; Sobanski V;
    Arthritis Res Ther; 2020 Feb; 22(1):30. PubMed ID: 32070422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autoantibodies to stratify systemic sclerosis patients into clinically actionable subsets.
    Mahler M; Hudson M; Bentow C; Roup F; Beretta L; Pilar Simeón C; Guillén-Del-Castillo A; Casas S; Fritzler MJ
    Autoimmun Rev; 2020 Aug; 19(8):102583. PubMed ID: 32553611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.